Skip to main content

Efficacy of ERAVAC® against a heterologous challenge with a virulent RHDV-2 strain in the presence and/or absence of maternal derived antibodies

Appeared in: 12th World Rabbit Congress, 2021
Authors: Montbrau, C.; Gascon, S.; Ruiz, M. C.

The aim of the present study was to evaluate the efficacy of ERAVAC® (HIPRA, Spain) under the influence of MDA against an experimental challenge using a heterologous RHDV-2 strain, in 1-month old rabbits.

Download this article